AACR 2026: Novel approach prevents cancer progression, spares surgery for majority of patients with precancerous oral lesions
Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral…
Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral…
A large international cohort study published in JAMA Oncology adds further weight to the case…
A quality improvement randomised clinical trial published in JAMA Network Open has found that behaviourally…
A phase 3 randomised, double-blind trial published in The Lancet has evaluated the addition of…
From cholangiocarcinoma to chrono-oncology, this episode explores whether promising signals are ready to translate into meaningful patient benefit. With thanks to our Host Craig Underhill, joined by Dr Kate Clarke and Professor Christopher Jackson…
A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialised high-dose…
A large systematic review and Bayesian network meta-analysis published in JAMA Network Open provides a…
PBS UPDATE SERIES 1 / EPISODE 2 The PBS Update Podcast: April 2026 Welcome to…
By Dr Dominique Lee Public trust in oncology relies on strong professional standards, transparent governance, and…
A new scientific study, published in Nature Health, reveals a strong link between exposure to agricultural pesticides…